Total Payments
$7,186
2024 Payments
$61.66
Companies
39
Transactions
455
Medicare Patients
3,355
Medicare Billing
$471,708
Payment Breakdown by Category
Food & Beverage$7,091 (98.7%)
Education$94.39 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,091 | 442 | 98.7% |
| Education | $94.39 | 13 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,529 | 108 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $907.89 | 59 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $866.29 | 57 | $0 (2023) |
| Grifols USA, LLC | $535.74 | 31 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $497.29 | 21 | $0 (2018) |
| United Therapeutics Corporation | $376.70 | 14 | $0 (2018) |
| Actelion Pharmaceuticals US, Inc. | $329.55 | 20 | $0 (2021) |
| Genentech USA, Inc. | $290.43 | 17 | $0 (2020) |
| Electromed, Inc. | $277.77 | 23 | $0 (2023) |
| Allergan, Inc. | $166.84 | 23 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $61.66 | 3 | PFIZER INC. ($61.66) |
| 2023 | $117.77 | 6 | PFIZER INC. ($54.92) |
| 2022 | $41.36 | 4 | Electromed, Inc. ($41.36) |
| 2021 | $229.95 | 13 | Janssen Pharmaceuticals, Inc ($153.70) |
| 2020 | $1,264 | 74 | GlaxoSmithKline, LLC. ($350.84) |
| 2019 | $1,322 | 89 | GlaxoSmithKline, LLC. ($320.41) |
| 2018 | $1,822 | 115 | GlaxoSmithKline, LLC. ($409.92) |
| 2017 | $2,328 | 151 | GlaxoSmithKline, LLC. ($448.08) |
All Payment Transactions
455 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/25/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: VACCINES | ||||||
| 04/29/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: VACCINES | ||||||
| 03/18/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: VACCINES | ||||||
| 09/18/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $40.26 | General |
| Category: RESPIRATORY | ||||||
| 05/18/2023 | PFIZER INC. | PREVNAR 20 (Biological), PAXLOVID, COMIRNATY | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: VACCINES | ||||||
| 03/16/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: VACCINES | ||||||
| 02/01/2023 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $11.76 | General |
| Category: HFCWO | ||||||
| 01/31/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: VACCINES | ||||||
| 01/04/2023 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $10.83 | General |
| Category: HFCWO | ||||||
| 11/09/2022 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $10.82 | General |
| Category: HFCWO | ||||||
| 10/12/2022 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $10.83 | General |
| Category: HFCWO | ||||||
| 04/06/2022 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $10.18 | General |
| Category: HFCWO | ||||||
| 01/12/2022 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $9.53 | General |
| Category: HFCWO | ||||||
| 11/16/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/21/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/07/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/01/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/12/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/29/2021 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Cardiology | ||||||
| 07/21/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/28/2021 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Cardiology | ||||||
| 06/24/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/14/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/11/2021 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Cardiology | ||||||
| 02/11/2021 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 669 | 1,192 | $529,117 | $88,282 |
| 2022 | 5 | 703 | 1,293 | $490,445 | $105,037 |
| 2021 | 6 | 831 | 1,672 | $604,980 | $137,508 |
| 2020 | 16 | 1,152 | 2,129 | $360,564 | $140,881 |
Total Patients
3,355
Total Services
6,286
Medicare Billing
$471,708
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 320 | 730 | $266,165 | $45,573 | 17.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 118 | 229 | $118,666 | $21,483 | 18.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 60 | 60 | $60,624 | $8,159 | 13.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 116 | 117 | $43,592 | $7,438 | 17.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 43 | 44 | $32,966 | $4,544 | 13.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 12 | 12 | $7,104 | $1,085 | 15.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 386 | 950 | $349,646 | $76,594 | 21.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 84 | 86 | $67,140 | $13,674 | 20.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 153 | 158 | $45,978 | $8,781 | 19.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 62 | 81 | $21,165 | $4,497 | 21.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 18 | 18 | $6,516 | $1,492 | 22.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 435 | 1,182 | $430,748 | $97,795 | 22.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 93 | 95 | $70,695 | $15,455 | 21.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 134 | 225 | $48,785 | $12,764 | 26.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 116 | 117 | $33,903 | $6,747 | 19.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 42 | 42 | $15,204 | $3,569 | 23.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 11 | 11 | $5,645 | $1,178 | 20.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 67 | 274 | $139,740 | $47,800 | 34.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 119 | 488 | $80,032 | $39,668 | 49.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 100 | 404 | $46,545 | $22,899 | 49.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 51 | 53 | $17,225 | $8,247 | 47.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 110 | 140 | $24,080 | $7,593 | 31.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 147 | 158 | $17,538 | $5,482 | 31.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 18 | 20 | $4,771 | $2,151 | 45.1% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Facility | 2020 | 35 | 35 | $7,070 | $1,894 | 26.8% |
About Dr. Gary Smith, MD
Dr. Gary Smith, MD is a Pulmonary Disease healthcare provider based in Lubbock, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1568454791.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Smith, MD has received a total of $7,186 in payments from pharmaceutical and medical device companies, with $61.66 received in 2024. These payments were reported across 455 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($7,091).
As a Medicare-enrolled provider, Smith has provided services to 3,355 Medicare beneficiaries, totaling 6,286 services with total Medicare billing of $471,708. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Lubbock, TX
- Active Since 08/15/2005
- Last Updated 10/12/2011
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1568454791
Products in Payments
- ANORO (Drug) $581.42
- SYMBICORT (Drug) $554.75
- ORENITRAM (Drug) $375.70
- STIOLTO RESPIMAT (Drug) $340.96
- TRELEGY ELLIPTA (Drug) $339.79
- OFEV (Drug) $337.52
- Esbriet (Biological) $309.48
- BREO (Drug) $306.49
- SMARTVEST (Device) $277.77
- Prolastin-C Liquid (Biological) $275.98
- Prolastin-C (Biological) $259.76
- BEVESPI AEROSPHERE (Drug) $207.99
- OPSUMIT (Drug) $190.83
- LONHALA MAGNAIR (Drug) $190.14
- ANORO ELLIPTA (Drug) $174.64
- STIOLTO (Drug) $172.65
- XARELTO (Drug) $153.70
- UTIBRON (Drug) $152.20
- GLASSIA (Biological) $128.04
- NUCALA (Biological) $126.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Lubbock
Shannon Turnbow, Md, MD
Pulmonary Disease — Payments: $22,266
Pulmonary Disease $22,266
Brian Williams, Md, MD
Pulmonary Disease — Payments: $16,308
Pulmonary Disease $16,308
Dr. Victor Test, M.d, M.D
Pulmonary Disease — Payments: $16,202
Pulmonary Disease $16,202
Marque Hunter, M.d, M.D
Pulmonary Disease — Payments: $15,691
Pulmonary Disease $15,691
Mark Johnson, Md, MD
Pulmonary Disease — Payments: $10,815
Pulmonary Disease $10,815
Srinivas Kadiyala, Md, MD
Pulmonary Disease — Payments: $9,235
Pulmonary Disease $9,235